The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR platform, marking the first patent issued for this point-of-care technology.
The lab, which expands upon an effort by UCSD and Scripps Research, will use wastewater analysis to detect flu, COVID and RSV ...
The global Clinical Microbiology Market is witnessing steady growth, driven by factors such as the rise in infectious diseases, government subsidization of healthcare, and increasing research funding.
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company specializing in enzymes ...
A new CRISPR-based approach for tuning gene expression up and down allowed identification of how other genes' expression ...
PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...
Evidence from multiple model systems supports a shift away from heme transport and toward metabolic dysfunction and oxidative stress as key drivers of TANGO2 deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback